JMP Securities Downgrades Uroplasty (UPI) to Market Perform
Tweet
Share
E-mailGet Alerts UPI Hot Sheet
Price: $1.22 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 6
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 6
Join SI Premium – FREE
JMP Securities downgraded Uroplasty (NASDAQ: UPI) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Uroplasty click here. For more ratings news on Uroplasty click here.
Shares of Uroplasty closed at $4.22 yesterday.
For an analyst ratings summary and ratings history on Uroplasty click here. For more ratings news on Uroplasty click here.
Shares of Uroplasty closed at $4.22 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Downgrades Legend Biotech Corp. (LEGN) to Perform, 'CEO/Partnership/Competition Overhangs to Cap Upside'
- UBS Downgrades Nihon Kohden Corp (6849:JP) to Neutral
- Kepler Cheuvreux Downgrades Merlin Properties SA (MRL:SM) (MRPRF) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
